Skip to main content
Top
Published in: Obesity Surgery 9/2008

01-09-2008 | Research Article

Improvement of Insulin Resistance After Obesity Surgery: A Comparison of Gastric Banding and Bypass Procedures

Authors: Wei-Jei Lee, Yi-Chih Lee, Kong-Han Ser, Jung-Chien Chen, Shu Chung Chen

Published in: Obesity Surgery | Issue 9/2008

Login to get access

Abstract

Background

Obesity is a major risk factor for the development of type 2 diabetes mellitus (T2DM). Insulin resistance (IR) is considered the pathologic link between T2DM and obesity. The mechanism in improving T2DM after bariatric surgery remains speculative. This trial assessed the effect of duodenal jejunal exclusion on the resolution of IR in gastric banding and gastric bypass procedures.

Methods

660 patients with complete biochemical and clinical data at baseline and at 3 years were selected for analysis. There were 197 males and 463 females. The mean age was 31.5 years (18–64) and mean BMI was 41.4 (32–77). There were 544 patients who received laparoscopic gastric bypass, and 116 patients received laparoscopic gastric banding. IR was measured by homeostatic model assessment (HOMA) index (HI), that can be calculated as HI = plasma glucose (mmol/l) × insulin (UI/ml)/22.5. HI was measured before surgery and 1, 3, 6, 12, 24, and 36 months after surgery.

Results

Of the 660 individuals, 517 (78.4%) had IR. The mean HI was 7.62 ± 13.13. The HI was correlated with BMI, waist circumference, insulin resistance, hyperlipidemia, inflammatory indicators, and abnormal liver enzymes. Before surgery, the HI was 7.92 ± 14.18 for the bypass group and 6.27 ± 6.47 for the banding group. After surgery, the HI began to lower in both groups, and this reduction was maintained during follow-up. At 36 months after surgery, mean percentage of excess weight loss (%EWL) was 70.5% for the bypass group and 41.9% for the banding group. The HI was 1.00 ± 0.79 for bypass and 1.51 ± 1.25 for banding. The bypass patients had a better and faster weight reduction, but the HI was similar between the two groups at the same weight reduction percentage.

Conclusion

IR is common in morbidly obese patients. Both gastric banding and gastric bypass are effective for the reverse of IR in these patients. It seems that the effect is related to the absolute weight loss rather than different surgical procedures. There is no duodenal jejunal exclusion effect on IR resolution was observed in this study.
Literature
1.
go back to reference Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–9.PubMedCrossRef Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–9.PubMedCrossRef
2.
go back to reference Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. JAMA. 1999;284:1530–8.CrossRef Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. JAMA. 1999;284:1530–8.CrossRef
3.
go back to reference Mokdad AH, Marks JS, Stroup DR, et al. Actual causes of death in the United States. 2000 JAMA. 2004;291:1238–45.CrossRef Mokdad AH, Marks JS, Stroup DR, et al. Actual causes of death in the United States. 2000 JAMA. 2004;291:1238–45.CrossRef
4.
go back to reference Jallut D, Golay A, Munger R, et al. Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. Metabolism. 1990;39:1068–75.PubMedCrossRef Jallut D, Golay A, Munger R, et al. Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. Metabolism. 1990;39:1068–75.PubMedCrossRef
5.
go back to reference Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1998;30:123–31.CrossRef Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1998;30:123–31.CrossRef
6.
go back to reference National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Int Med. 2000;160:898–904.CrossRef National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Int Med. 2000;160:898–904.CrossRef
7.
go back to reference Matthews DR, Hosker JP, Rudensky AS, et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–9.PubMedCrossRef Matthews DR, Hosker JP, Rudensky AS, et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–9.PubMedCrossRef
8.
go back to reference Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation provides to be the most effective therapy for adult onset diabetes mellitus. Ann Surg. 1995;222:339–52.PubMedCrossRef Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation provides to be the most effective therapy for adult onset diabetes mellitus. Ann Surg. 1995;222:339–52.PubMedCrossRef
9.
go back to reference Dixon JB, O’Brien PE. Health outcomes of severely obese type 2 diabetes subjects 1 year after laparoscopic adjustable gastric banding. Diabetes C. 2002;25:358–63.CrossRef Dixon JB, O’Brien PE. Health outcomes of severely obese type 2 diabetes subjects 1 year after laparoscopic adjustable gastric banding. Diabetes C. 2002;25:358–63.CrossRef
10.
go back to reference Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef
11.
go back to reference Gumbs AA, Modlin IM, Ballantyne GH. Changed in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15:462–73.PubMedCrossRef Gumbs AA, Modlin IM, Ballantyne GH. Changed in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15:462–73.PubMedCrossRef
12.
go back to reference Hickey MS, Pories WJ, MacDonald KG, et al. A new paradigm for type 2 diabetes mellitus. could it be a disease of the foregut? Ann Surg. 1998;227:637–44.PubMedCrossRef Hickey MS, Pories WJ, MacDonald KG, et al. A new paradigm for type 2 diabetes mellitus. could it be a disease of the foregut? Ann Surg. 1998;227:637–44.PubMedCrossRef
13.
go back to reference Greenway SE, Greenway EL, Klevin S. Effected of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg. 2002;137:1109–17.PubMedCrossRef Greenway SE, Greenway EL, Klevin S. Effected of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg. 2002;137:1109–17.PubMedCrossRef
14.
go back to reference Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236–42.PubMedCrossRef Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236–42.PubMedCrossRef
15.
go back to reference Rubino F, Marescaux J. Effects of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1–11.PubMedCrossRef Rubino F, Marescaux J. Effects of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1–11.PubMedCrossRef
16.
17.
go back to reference Wang W, Wei PL, Lee YC, et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15:648–54.PubMedCrossRef Wang W, Wei PL, Lee YC, et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15:648–54.PubMedCrossRef
18.
go back to reference Lee WJ, Wang W, Yu PJ, et al. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg. 2006;16:586–91.PubMedCrossRef Lee WJ, Wang W, Yu PJ, et al. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg. 2006;16:586–91.PubMedCrossRef
19.
go back to reference Doar JW, Wilde CE, Thompson ME, et al. Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity onset diabetes mellitus. Lancet. 1975;1(7919):1263–6.PubMedCrossRef Doar JW, Wilde CE, Thompson ME, et al. Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity onset diabetes mellitus. Lancet. 1975;1(7919):1263–6.PubMedCrossRef
20.
go back to reference Kelly DE, Wing R, Buonocore C, et al. Relative effect soft calorie restriction and weight loss in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1993;77:1287–93.CrossRef Kelly DE, Wing R, Buonocore C, et al. Relative effect soft calorie restriction and weight loss in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1993;77:1287–93.CrossRef
21.
go back to reference Ash S, Reeves MM, Yeo S, et al. Effect of intensive dietetic interventions on weight and glycemic control in overweight men with type II diabetes: a randomized trial. Int J Obes. 2003;27:797–802.CrossRef Ash S, Reeves MM, Yeo S, et al. Effect of intensive dietetic interventions on weight and glycemic control in overweight men with type II diabetes: a randomized trial. Int J Obes. 2003;27:797–802.CrossRef
22.
go back to reference Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM. 2001;344:1343–50.PubMedCrossRef Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM. 2001;344:1343–50.PubMedCrossRef
23.
go back to reference Harder H, Dinesen B, Astrup A. The effect of rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic patients. Int J Obes. 2004;28:180–2.CrossRef Harder H, Dinesen B, Astrup A. The effect of rapid weight loss on lipid profile and glycemic control in obese type 2 diabetic patients. Int J Obes. 2004;28:180–2.CrossRef
24.
go back to reference Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242:20–8.PubMedCrossRef Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242:20–8.PubMedCrossRef
25.
go back to reference Flum DR, Salem L, Elrod JAB, et al. Early mortality among medicare beneficiaries undergoing bariatric surgical procedures. JAMA. 2005;294:1903–8.PubMedCrossRef Flum DR, Salem L, Elrod JAB, et al. Early mortality among medicare beneficiaries undergoing bariatric surgical procedures. JAMA. 2005;294:1903–8.PubMedCrossRef
26.
go back to reference Lee WJ, Chen HH, Wang W, et al. Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan. J Formos Med Assoc. 2003;102:459–64.PubMed Lee WJ, Chen HH, Wang W, et al. Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan. J Formos Med Assoc. 2003;102:459–64.PubMed
27.
go back to reference Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on metabolic syndrome. Arch Surg. 2004;139:1088–92.PubMedCrossRef Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on metabolic syndrome. Arch Surg. 2004;139:1088–92.PubMedCrossRef
28.
go back to reference Sjostrom L, Narbro K, Sjostrom D, et al. Effect of bariatric surgery on mortality in Swedish obese subjects. NEJM. 2007;357:741–52.PubMedCrossRef Sjostrom L, Narbro K, Sjostrom D, et al. Effect of bariatric surgery on mortality in Swedish obese subjects. NEJM. 2007;357:741–52.PubMedCrossRef
29.
go back to reference O’Brien PE, Dixon JB, Laurie, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. Ann Intern Med. 2006;144:625–33.PubMed O’Brien PE, Dixon JB, Laurie, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. Ann Intern Med. 2006;144:625–33.PubMed
Metadata
Title
Improvement of Insulin Resistance After Obesity Surgery: A Comparison of Gastric Banding and Bypass Procedures
Authors
Wei-Jei Lee
Yi-Chih Lee
Kong-Han Ser
Jung-Chien Chen
Shu Chung Chen
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 9/2008
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9457-3

Other articles of this Issue 9/2008

Obesity Surgery 9/2008 Go to the issue